Gacerez, Albert T.
Hua, Casey K.
Ackerman, Margaret E.
Sentman, Charles L.
Funding for this research was provided by:
National Institutes of Health (8P30GM103415)
Center for Synthetic Immunity
The Elmer R. Pfefferkorn and Allan U. Munck Education and Research Fund
Article History
Received: 31 August 2017
Accepted: 6 February 2018
First Online: 16 February 2018
Conflict of interest
: All authors have patent applications in antibody-based therapies and cell engineering. These conflicts are managed under the policies of Dartmouth College.
: All procedures involving mice were in accordance with the ethical standards set forth by the Dartmouth College’s Institution Animal Care and Use Committee.
: C57BL/6 (B6) mice from Charles River.
: ATCC authenticated K562 on August 25, 2016 and SH-SY5Y on October 27, 2016. Murine cell lines were obtained from 2001 to 2006. RMA cell lines were obtained from Michael Bennett (UT Southwestern Medical Center) and B16F10 cell lines were obtained from Richard Barth (Geisel School of Medicine at Dartmouth).